BCR-ABL1-induced leukemogenesis and autophagic targeting by arsenic trioxide. [electronic resource]
Producer: 20130715Description: 93-4 p. digitalISSN:- 1554-8635
- Antineoplastic Agents -- pharmacology
- Arsenic Trioxide
- Arsenicals
- Autophagy -- drug effects
- Fusion Proteins, bcr-abl -- metabolism
- Humans
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Models, Biological
- Neoplastic Stem Cells -- drug effects
- Oxides -- toxicity
- Translational Research, Biomedical
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.